Profile
Yun Han Lin formerly worked at Sinphar Pharmaceutical Co. Ltd., as Deputy Manager-Science Project from 2001 to 2012, Mycenax Biotech, Inc., as Head-Business Development from 2016 to 2017, SynCore Biotechnology Co., Ltd., as Head-Business Development from 2012 to 2015, and I-Mab, as Vice President-Corporate Development.
Dr. Lin received his doctorate degree in 2008 from the University of Tamkang, undergraduate degree in 2000 from Providence University, and graduate degree in 2003 from Fu Jen Catholic University.
Former positions of Yun Han Lin
| Companies | Position | End |
|---|---|---|
| MYCENAX BIOTECH INC. | Corporate Officer/Principal | 01/09/2017 |
| SYNCORE BIOTECHNOLOGY CO.,LTD | Corporate Officer/Principal | 01/12/2015 |
| SINPHAR PHARMACEUTICAL CO.,LTD. | Corporate Officer/Principal | 01/01/2012 |
| NOVABRIDGE BIOSCIENCES | Corporate Officer/Principal | - |
Training of Yun Han Lin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Sinphar Pharmaceutical Co. Ltd.
Sinphar Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Tamkang
University of Tamkang Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence University
Providence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mycenax Biotech, Inc.
Mycenax Biotech, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Fu Jen Catholic University
Fu Jen Catholic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SynCore Biotechnology Co., Ltd.
SynCore Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of new drugs and integration of technology | Health Technology |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Yun Han Lin
















